Jill Wechsler, ACT's Washington Correspondent

Jill Wechsler is ACT's Washington Correspondent

Articles

Congress Slated to Reauthorize User Fees, Without FDA ‘Improvements’

September 23, 2022

Seek pared-down measure in funding bill to avert shutdown.

Clinical Trial Modernization Raises FDA Compliance Issues

September 20, 2022

Agency officials express associated concerns around clinical trial data reliability and quality.

Advanced Biopharma Manufacturing Key to White House Cancer Moonshot

September 16, 2022

Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions.

FDA in Limbo as User Fee Renewal Stuck on Capitol Hill

September 12, 2022

In countdown to renewal deadline, agency already feeling the effects of still-unclear legislative fate.

New Legislation Overhauls Medicare Drug Pricing and Benefits

August 15, 2022

Pharma loses battle to block price negotiations, but implementation faces many challenges.